Edwards Lifesciences Corp Cash & Equivalents 2007-2026 | EW
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Edwards Lifesciences Corp's current cash & equivalents?
Edwards Lifesciences Corp (EW) annual cash & equivalents for 2025 was $2.94B, a 3.90% decline from 2024. Edwards Lifesciences Corp cash & equivalents for the quarter ending March 31, 2026 was $2.45B.
What was Edwards Lifesciences Corp's cash & equivalents in 2024?
Edwards Lifesciences Corp annual cash & equivalents for 2024 was $3.06B, a 166.45% increase from 2023.
What was Edwards Lifesciences Corp's cash & equivalents in 2023?
Edwards Lifesciences Corp annual cash & equivalents for 2023 was $1.15B, a 48.59% increase from 2022.
What is Edwards Lifesciences Corp's 5-year cash & equivalents CAGR?
Edwards Lifesciences Corp cash & equivalents grew at a compound annual growth rate (CAGR) of 19.62% from FY2020 to FY2025, going from $1.20B to $2.94B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.94B | -3.9% | 10-K |
| FY2024 | $3.06B | +166.4% | 10-K |
| FY2023 | $1.15B | +48.6% | 10-K |
| FY2022 | $772.6M | -10.9% | 10-K |
| FY2021 | $867.4M | -27.7% | 10-K |
| FY2020 | $1.20B | +1.3% | 10-K |
| FY2019 | $1.18B | +65.4% | 10-K |
| FY2018 | $715.9M | -12.5% | 10-K |
| FY2017 | $818.3M | -12.0% | 10-K |
| FY2016 | $930.1M | +29.5% | 10-K |
| FY2015 | $718.4M | +9.9% | 10-K |
| FY2014 | $653.8M | +55.5% | 10-K |
| FY2013 | $420.4M | +35.2% | 10-K |
| FY2012 | $310.9M | +81.6% | 10-K |
| FY2011 | $171.2M | -56.8% | 10-K |
| FY2010 | $396.1M | +18.6% | 10-K |
| FY2009 | $334.1M | +52.8% | 10-K |
| FY2008 | $218.7M | +54.2% | 10-K |
| FY2007 | $141.8M | - | 10-K |